Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B

Adefovir (ADV) sequential monotherapy was included in the 2005 Asia-Pacific guidelines for the management of patients with lamivudine (LAM) resistance. However, following the development of ADV resistance, the proportion of resistant variants during combined rescue therapy with ADV and entecavir (ET...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Exp Ther Med
Hlavní autoři: WANG, YANG, LIU, SHUANG, CHEN, YU, ZHENG, SUJUN, ZHOU, LI, LU, FENGMIN, DUAN, ZHONGPING
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2016
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4888018/
https://ncbi.nlm.nih.gov/pubmed/27313669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3230
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky